Haemonetics Corporation (HAE)
Total asset turnover
| Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 1,360,820 | 1,309,060 | 1,168,660 | 993,196 | 870,463 |
| Total assets | US$ in thousands | 2,450,950 | 2,195,590 | 1,934,820 | 1,859,730 | 1,819,920 |
| Total asset turnover | 0.56 | 0.60 | 0.60 | 0.53 | 0.48 |
March 31, 2025 calculation
Total asset turnover = Revenue ÷ Total assets
= $1,360,820K ÷ $2,450,950K
= 0.56
The total asset turnover ratio for Haemonetics Corporation has shown an improving trend over the past few years. In March 2021, the total asset turnover ratio was 0.48, indicating that the company generated $0.48 in sales for every $1 of assets. By March 2023, this ratio had increased to 0.60, suggesting that the company was more efficient in utilizing its assets to generate revenue. This improvement was maintained in March 2024, with the total asset turnover ratio remaining at 0.60, indicating continued efficiency in asset utilization.
However, the data for March 2025 is unavailable, denoted by a dash (—), making it challenging to evaluate the company's performance for that year. Overall, the increasing trend in the total asset turnover ratio from 2021 to 2024 suggests that Haemonetics Corporation has been effectively managing its assets to drive sales growth.
Peer comparison
Mar 31, 2025